Janet Hopkins
Direttore Tecnico/Scientifico/R&S presso AURA BIOSCIENCES, INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Elisabet de los Pinos | M | 51 | 17 anni | |
| Raj Bhikhu Parekh | M | 63 | 9 anni | |
| Daniel Hochstrasser | M | 64 | 2 anni | |
| John Young | M | 60 | 1 anni | |
| Ana de Pro Gonzalo | F | 57 | 2 anni | |
| Karan Takhar | M | 32 | 3 anni | |
| Giovanni Mariggi | M | 39 | 5 anni | |
| Antony Mattessich | M | 57 | 3 anni | |
| David Johnson | M | 59 | 3 anni | |
| Sapna R. Srivastava | M | 53 | 3 anni | |
| Alex Dasalla | M | - | 2 anni | |
| Edward Lang | M | 44 | 5 anni | |
| Amy Elazzouzi | F | - | - | |
| Chinmay Umesh Bhatt | M | 51 | - | |
| Carrie Murray | M | - | - | |
| Ian Pitfield | M | 58 | 4 anni | |
| Julie Feder | F | 54 | 6 anni | |
| Jane Hughes | M | 50 | 5 anni | |
| Joseph Lyons | M | - | 3 anni | |
| Jason Mark Brooks | M | 52 | - | |
| Shreeram Aradhye | M | 62 | 2 anni | |
| Mark Plavsic | M | 63 | 1 anni | |
| Aharon Gal | M | 58 | 2 anni | |
| Anthony Adamis | M | 65 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 3 anni |
| Kees Roks | M | 61 | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John Tsai | M | 57 | 4 anni | |
| Eric Boutin | M | - | 3 anni | |
| Seshu Tyagarajan | M | 57 | 2 anni | |
| Maha Katabi | M | 50 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 1 anni |
| Chris Hollowood | M | 50 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 6 anni |
| Renée Galá | F | 52 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 2 anni |
| Elizabeth Theophille | F | 57 | 7 anni | |
| Cadmus Rich | M | 59 | 6 anni | |
| Dominic Schmidt | M | 42 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 3 anni |
| Marie-France Tschudin | F | 53 | 1 anni | |
| Natacha Theytaz | M | - | 4 anni | |
| Paulo Carvalho | M | - | 3 anni | |
| Lutz Hegemann | M | 58 | - | |
| Amy Wolf | F | - | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 15 | 38.46% |
| Svizzera | 14 | 35.90% |
| Regno Unito | 10 | 25.64% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Janet Hopkins
- Contatti personali
